Toshihiro Sato Selected Research

Toshihiro Sato Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 01/2010
6	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2013
4	Neoplasm Metastasis (Metastasis) 03/2021 - 02/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 03/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2020 - 02/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2017
2	Colorectal Neoplasms (Colorectal Cancer) 04/2019 - 02/2018
2	Stomach Neoplasms (Stomach Cancer) 02/2019 - 08/2002
2	Carcinoma (Carcinomatosis) 02/2018 - 08/2002
1	Infections 04/2022
1	Chronic Hepatitis B 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 04/2022
1	Pathologic Constriction (Stenosis) 03/2022
1	Peritonitis 02/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Neuroblastoma 11/2021
1	Leukemia 08/2021
1	Treatment-Resistant Schizophrenia 07/2021
1	Liver Cell Adenoma (Hepatocellular Adenoma) 06/2021
1	Breast Neoplasms (Breast Cancer) 03/2021
1	Cholangiocarcinoma 03/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	COVID-19 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Spontaneous Remission 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Niemann-Pick Diseases (Niemann Pick Disease) 09/2020
1	Liver Neoplasms (Liver Cancer) 08/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2020
1	Iron Overload 03/2020
1	Hemochromatosis (Bronze Diabetes) 03/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2019
1	Neutropenia 12/2019
1	Hydronephrosis 04/2019

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 07/2021 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2021
2	Hormones (Hormone)IBA 04/2022 - 03/2021
2	CholesterolIBA 04/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 08/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2010
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2018
2	EnzymesIBA 01/2019 - 03/2007
2	Gefitinib (Iressa)FDA Link 02/2008 - 06/2004
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 03/2007 - 07/2006
1	Alanine Transaminase (SGPT)IBA 04/2022
1	nasIBA 04/2022
1	SteroidsIBA 04/2022
1	Serum AlbuminIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021
1	Protein Disulfide-IsomerasesIBA 11/2021
1	Dasatinib (BMS 354825)FDA Link 08/2021
1	bosutinibIBA 08/2021
1	nilotinib FDA Link 08/2021
1	Imatinib Mesylate (Gleevec)FDA Link 08/2021
1	ibrutinibIBA 08/2021
1	Clozapine (Clozaril)FDA LinkGeneric 07/2021
1	Protons (Proton)IBA 06/2021
1	Letrozole (Femara)FDA LinkGeneric 03/2021
1	Growth Factor ReceptorsIBA 03/2021
1	abemaciclibIBA 03/2021
1	Aromatase InhibitorsIBA 03/2021
1	Cyclin-Dependent Kinase 4IBA 03/2021
1	ribociclibIBA 03/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 03/2021
1	Fulvestrant (Faslodex)FDA Link 03/2021
1	palbociclibIBA 03/2021
1	Estrogen Receptor AntagonistsIBA 03/2021
1	GadoliniumIBA 03/2021
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2021
1	diethylenetriamineIBA 03/2021
1	PENTAIBA 03/2021
1	remdesivirIBA 01/2021
1	NucleosidesIBA 01/2021
1	GS-441524IBA 01/2021
1	sphingosine phosphorylcholineIBA 09/2020
1	Phosphorylcholine (Phosphocholine)IBA 09/2020
1	Serine (L-Serine)FDA Link 09/2020
1	QuercetinIBA 08/2020
1	Fluorouracil (Carac)FDA LinkGeneric 08/2020
1	Cyclin D1IBA 03/2020
1	IronIBA 03/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020

Therapy/Procedure

6	Therapeutics 04/2022 - 01/2013
3	Catheters 03/2022 - 01/2016
2	Hepatectomy 03/2021 - 04/2019
2	Pancreaticoduodenectomy 04/2020 - 02/2019
1	Peritoneal Dialysis 02/2022
1	Radiofrequency Ablation 12/2021
1	Radiotherapy 06/2021
1	Renal Dialysis (Hemodialysis) 01/2021
1	Urinary Diversion (Ileal Conduit) 12/2020
1	Cholecystectomy 12/2019
1	Adjuvant Chemotherapy 04/2019